CF Foun­da­tion, Long­wood team on new in­cu­ba­tor for com­pa­nies with cut­ting-edge CF treat­ments

Nine months af­ter launch­ing a $500 mil­lion hunt for a cure for cys­tic fi­bro­sis, the Cys­tic Fi­bro­sis Foun­da­tion said it will use a por­tion of those funds to do some­thing it has nev­er done be­fore: help launch new com­pa­nies.

The CF Foun­da­tion, whose ven­ture phil­an­thropy ef­forts helped fund Ver­tex’s line of pow­er­ful CF drugs, is team­ing with Long­wood Fund to cre­ate a CF in­cu­ba­tor. The in­cu­ba­tor will iden­ti­fy new com­pa­nies with plat­forms or tech­nolo­gies that can be ap­plied in the rare ge­net­ic con­di­tion. The part­ners can then fi­nance ear­ly de­vel­op­ment in ex­change for a com­mit­ment from the com­pa­nies to fo­cus on ap­pli­ca­tions in cys­tic fi­bro­sis.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.